Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 65-72 , March 2005

Topical ALA–PDT modifies neutrophils’ chemiluminescence, lymphocytes’ interleukin-1beta secretion and serum level of transforming growth factor beta1 in patients with nonmelanoma skin malignancies: A clinical study

  • Mariusz Adamek, MD, PhD

      Affiliations

    • Center for Laser Diagnostics and Therapy, Chair and Clinic of Internal Diseases and Physical Medicine, Silesian Medical University, 15 Batory St., PL-41902 Bytom, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 32 786 1616; fax: +48 32 786 1630.
    • ,
  • Aleksandra Kawczyk-Krupka

      Affiliations

    • Center for Laser Diagnostics and Therapy, Chair and Clinic of Internal Diseases and Physical Medicine, Silesian Medical University, 15 Batory St., PL-41902 Bytom, Poland
    • ,
  • Aleksandra Mostowy

      Affiliations

    • Department of Microbiology and Immunology, Silesian Medical University, 19 Jordana St., PL-41808 Zabrze-Rokitnica, Poland
    • ,
  • Zenon Czuba

      Affiliations

    • Department of Microbiology and Immunology, Silesian Medical University, 19 Jordana St., PL-41808 Zabrze-Rokitnica, Poland
    • ,
  • Wojciech Krol

      Affiliations

    • Department of Microbiology and Immunology, Silesian Medical University, 19 Jordana St., PL-41808 Zabrze-Rokitnica, Poland
    • ,
  • Slawomir Kasperczyk

      Affiliations

    • Department of Biochemistry, Silesian Medical University, 19 Jordana St., PL-41808 Zabrze-Rokitnica, Poland
    • ,
  • Marek Jakobisiak

      Affiliations

    • Department of Immunology, Center of Biostructure Research, The Medical University of Warsaw, Chalubinskiego 5, PL-02004 Warsaw, Poland
    • ,
  • Jakub Golab

      Affiliations

    • Department of Immunology, Center of Biostructure Research, The Medical University of Warsaw, Chalubinskiego 5, PL-02004 Warsaw, Poland
    • ,
  • Aleksander Sieron

      Affiliations

    • Center for Laser Diagnostics and Therapy, Chair and Clinic of Internal Diseases and Physical Medicine, Silesian Medical University, 15 Batory St., PL-41902 Bytom, Poland

References 

  1. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2–31
  2. Dougherty TJ. Photodynamic therapy: status and potential. Oncology. 1989;3:67–78
  3. Gomer CJ. Photodynamic therapy in the treatment of malignancies. Semin Hematol. 1989;26:27–34
  4. Sieron A, Cieslar G, Adamek M, Laitl-Kobierska A, Szygula M, Kawczyk-Krupka A. Zarys fotodynamicznej diagnostyki i terapii nowotworów. Bielsko-Biala: Alpha-medica Press; 1997;
  5. Korbelik M, Krosl G, Adomat H, Skov KA. The effect of differentiation on photosensitizer uptake by HL60 cells. Photochem Photobiol. 1993;58:670–675
  6. Korbelik M, Dougherty TJ. Photodynamic therapy-mediated immune response against subcutaneus mouse tumors. Cancer Res. 1999;59:1941–1946
  7. Vonarx V, Foultier MT, Anasagasti L, Morlet L, Lajat Y, Patrice T. Photodynamic effect on the specific antitumor immune activity. Int J Immunopharmacol. 1997;19:101–110
  8. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminium disulfonated phtalocyanines and laser light. Anticancer Drugs. 1994;5:443–447
  9. Vancikova Z. Principles of the photodynamic therapy and its impact on the immune system. Sb Lek. 1998;99:1–11
  10. Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14:329–334
  11. Tosk J, Lau BHS, Lui P, Myers RC, Torrey RR. Chemiluminescence in a macrophage cell line modulated by biological response modifiers. J Leukoc Biol. 1989;46:103–108
  12. Coutier S, Bezdetnaya L, Marchal S, et al. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and TNFα-mediated cytolytic activity. Br J Cancer. 1999;81:37–42
  13. Korbelik M, Cecic I. Enhancement of tumor response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J Photochem Photobiol B. 1998;44:151–158
  14. Krosl G, Korbelik M, Krosl J, Dougherty GJ. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 1996;56:3281–3286
  15. Korbelik M, Cecic I. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. 1999;137:91–98
  16. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med. 1987;317:687–694
  17. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365–376
  18. Clark RA, Klebanoff SJ. Neutrophil mediated tumor cell cytotoxicity. Role of the peroxide system. J Exp Med. 1975;141:1442–1447
  19. Smith JA. Neutrophils host defense and inflammation: a double-edged sword. J Leukoc Biol. 1994;56:672–691
  20. Fossat C, Saintry D, Stoppa AM. In vivo cytokines effects on polymorphonuclear cells function. Clin Haematol. 1992;12:67–78
  21. Perusia B, Kobayashi M, Rossi ME, Anegon I, Trinchieri G. Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor and granulocyte-macrophage colony stimulating factor. J Immunol. 1987;138:765–774
  22. Burt HM, Jackson JK. The priming action of tumor necrosis factor alpha (TNFα) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophils activated by inflammatory microcrystals. Clin Exp Immunol. 1997;108:432–437
  23. Boehncke WH, Konig K, Kaufmann R, Scheffold W, Prummer O, Sterry W. Photodynamic therapy in psoriasis: supression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res. 1994;286:300–303
  24. Neuner P, Charvat B, Knobler R, et al. Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsolaren plus UV-A. Photochem Photobiol. 1994;59:182–188
  25. Tokura Y, Yagi J, Edelson RL, Gasparro FP. Inhibitory effect of 8-metoxypsolaren plus ultraviolet-A on interleukin-1 production by murine keratinocytes. Photochem Photobiol. 1991;53:517–523
  26. De Vree WJ, Essers MC, Koster JF, Sluiter W. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 1997;57:2555–2558
  27. Kick G, Messer G, Plewig G, Kind P, Goetz AE. Strong and prolonged induction of c-jun and c-fos protooncogens by photodynamic therapy. Br J Cancer. 1996;74:30–36
  28. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszyńska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol. 1995;58:667–674
  29. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacology. 1991;43:109–142
  30. Taylor-Robinson AW, Liew FY, Severn A, et al. Regulation of the immune response by nitric oxide differentially produced by T-helper type 1 and T-helper type 2 cells. Eur J Immunol. 1994;24:980–984
  31. Lawrence DA. Transforming growth factor-beta: a general review. Eur Cytokine Netw. 1996;7:363–374
  32. Yoshinaga K, Mimori K, Yamashita K, Utsonomiya T, Inoue H, Mori M. Clinical significance of the expression of activin A in esophageal carcinoma. Int J Oncol. 2003;22:75–80
  33. Statius van Eps RG, LaMuraglia GM. Photodynamic therapy inhibits transforming growth factor beta activity associated with vascular smooth muscle cell injury. J Vasc Surg. 1997;25:1044–1053
  34. Statius van Eps RG, Adili F, Watkins MT, Anderson RR, LaMuraglia GM. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-beta. Lab Invest. 1997;76:257–266
  35. Breider MA, Lu X, Panjehpour M, Frazier DL. Cytokine modulation of endothelial cell sensitivity to photodynamic therapy. Lasers Surg Med. 1993;13:305–311
  36. Usuda J, Okunaka T, Furukawa K, et al. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int J Cancer. 2001;93:475–480
  37. Lai JP, Tao ZD, Xiao JY, Zhao SP, Tian YQ. Effect of photodynamic therapy on selected laboratory values of patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol. 1997;106:680–682
  38. Herman S, Kalechman Y, Gafter U, Sredni B, Malik Z. Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. Immunopharmacology. 1996;31:195–204
  39. Gollnik SO, Liu X, Owczarczak B, Musser DA, Henderson BW. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 1997;57:3904–3909
  40. Cecic I, Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 2002;183:43–51
  41. Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo ML. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene. 2001;20:198–208

PII: S1572-1000(05)00004-9

doi: 10.1016/S1572-1000(05)00004-9

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 65-72 , March 2005

Article Tools

* Image Usage & Resolution